Literature DB >> 10917344

Results of transsphenoidal surgery for Cushing's disease in patients with no histologically confirmed tumor.

J M Sheehan1, M B Lopes, J P Sheehan, D Ellegala, K M Webb, E R Laws.   

Abstract

OBJECTIVE: Pathological confirmation of surgical resection of an adenoma for Cushing's disease is not always achieved. We reviewed our experience to determine the prognostic significance of this lack of confirmation regarding outcome, and we evaluate explanations for this situation.
METHODS: The records of all patients undergoing transsphenoidal surgery for Cushing's disease from 1992 to 1998 were reviewed, and those with no histological confirmation of tumor were identified. Information regarding preoperative and postoperative hormonal levels and clinical symptoms, preoperative magnetic resonance imaging data, intraoperative findings, and the number of reoperations were recorded.
RESULTS: There were 29 patients with no confirmation of tumor. Nineteen (66%) of these patients were cured with surgery and only one had a recurrence of disease, with an average follow-up of 38 months. An abnormality thought to represent an adenoma at the time of surgery was removed in 26 patients (90%). Preoperative magnetic resonance imaging suggested a discrete lesion in 21 patients (72%). Neither intraoperative impression nor magnetic resonance imaging appearance was correlated with outcome.
CONCLUSION: Patients with no histological confirmation of tumor after transsphenoidal surgery for Cushing's disease are likely to have a good outcome. The results do not differ significantly from reported cure rates in patients with confirmed adenomas. Possible explanations for this situation are discussed.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10917344     DOI: 10.1097/00006123-200007000-00008

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  9 in total

1.  Outcome of using the histological pseudocapsule as a surgical capsule in Cushing disease.

Authors:  Jay Jagannathan; Rene Smith; Hetty L DeVroom; Alexander O Vortmeyer; Constantine A Stratakis; Lynnette K Nieman; Edward H Oldfield
Journal:  J Neurosurg       Date:  2009-09       Impact factor: 5.115

Review 2.  The Treatment of Cushing's Disease.

Authors:  Rosario Pivonello; Monica De Leo; Alessia Cozzolino; Annamaria Colao
Journal:  Endocr Rev       Date:  2015-06-11       Impact factor: 19.871

Review 3.  Stereotactic radiosurgery for pituitary adenomas: a review of the literature.

Authors:  Edward R Laws; Jason P Sheehan; Jonas M Sheehan; Jay Jagnathan; John A Jane; Rod Oskouian
Journal:  J Neurooncol       Date:  2004 Aug-Sep       Impact factor: 4.130

4.  Transsphenoidal surgery for Cushing disease: experience with 136 patients.

Authors:  Ivan Ciric; Jin-Cheng Zhao; Hongyan Du; James W Findling; Mark E Molitch; Roy E Weiss; Samuel Refetoff; William D Kerr; Joel Meyer
Journal:  Neurosurgery       Date:  2012-01       Impact factor: 4.654

Review 5.  Cushing Disease: Medical and Surgical Considerations.

Authors:  David P Bray; Rima S Rindler; Reem A Dawoud; Andrew B Boucher; Nelson M Oyesiku
Journal:  Otolaryngol Clin North Am       Date:  2022-03-04       Impact factor: 1.866

Review 6.  Transsphenoidal surgery.

Authors:  Shabin Man Joshi; Simon Cudlip
Journal:  Pituitary       Date:  2008       Impact factor: 4.107

7.  Preliminary Experience with 3-Tesla MRI and Cushing's Disease.

Authors:  Louis J Kim; Gregory P Lekovic; William L White; John Karis
Journal:  Skull Base       Date:  2007-07

8.  Combination therapy for Cushing's disease: effectiveness of two schedules of treatment: should we start with cabergoline or ketoconazole?

Authors:  M Barbot; N Albiger; F Ceccato; M Zilio; A C Frigo; L Denaro; F Mantero; C Scaroni
Journal:  Pituitary       Date:  2014-04       Impact factor: 4.107

9.  MASEP gamma knife radiosurgery for secretory pituitary adenomas: experience in 347 consecutive cases.

Authors:  Heng Wan; Ohye Chihiro; Shubin Yuan
Journal:  J Exp Clin Cancer Res       Date:  2009-03-11
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.